The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Hospitals Brace for 2026 World Cup Surge in 11 US Cities

Hospitals and health systems across the 11 U.S. host cities for the 2026 FIFA World Cup have spent months preparing for an event that kicks off June 11 and is expected to be the largest in tournament history, according to Becker's Hospital Review. The competition will bring millions of international visitors to North America for 104 matches across the U.S., Canada and Mexico.

The influx creates distinct operational challenges. Health systems are planning for emergency department surges as crowds concentrate around stadiums and fan events. They are also watching for infectious disease risks, including measles, as travelers arrive from regions with varying vaccination rates and active outbreaks.

The financial strain is just as real. Many foreign visitors lack U.S. insurance coverage, leaving hospitals exposed to unpaid bills for emergency care they are obligated to provide. For host-city systems, the World Cup is both a public health stress test and a reminder of how mass gatherings expose gaps in capacity, surveillance and reimbursement.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.